Scholarlink

Background <p>Bloodstream infections (BSI) cause major morbidity and mortality in hemodialysis patients, yet contemporary Saudi data on pathogens, antimicrobial resistance, and outcomes remain limited. We described epidemiology, antimicrobial susceptibility, multidrug-resistant (MDR) phenotype prevalence, and unadjusted associations between MDR phenotypes and 30-day in-hospital mortality among maintenance hemodialysis BSI episodes.</p> Methods <p>This single-center retrospective cohort included maintenance hemodialysis patients with positive blood cultures at Aseer Central Hospital, southern Saudi Arabia, from January 2013 through July 2024. Analyses were structured by unit of analysis: unique patients, BSI episodes (after 14-day deduplication), isolates, and hospitalized episodes for mortality. Susceptibility used CLSI M100 categorical results. Unadjusted risk ratios with 95% confidence intervals and Fisher exact tests were descriptive; no multivariable model was fitted (sparse events).</p> Results <p>201 patients contributed 297 BSI episodes and 389 isolates; 234 hospitalized. Gram-positive organisms predominated (69.0%), led by staphylococci other than <i>Staphylococcus aureus</i> (SOSA, 42.8%), Enterobacterales (21.2%), and <i>S. aureus</i> (17.2%). The 30-day in-hospital mortality was 11.1% (26/234). Linezolid (99.2%) and vancomycin (96.0%) were most active; fluoroquinolone susceptibility was low (45–49%). MDR phenotypes occurred in 24.2% of isolates (MRSA 56.4%, ESC-R 65.0%, CRE 27.3%, VRE 29.2%, CRAB 80.0%). Organism-restricted analysis found CRE-positive episodes with higher mortality than carbapenem-susceptible Enterobacterales (3/8 vs. 1/21), without conventional significance (risk ratio 7.88, 95% CI 0.95–65.06; <i>P</i> = 0.053).</p> Conclusions <p>BSI were predominantly gram-positive with a substantial gram-negative and MDR burden. The CRE-mortality association was unadjusted, imprecise, and hypothesis-generating, requiring confirmation in larger adjusted cohorts. Findings support local antimicrobial stewardship and active MDR surveillance.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Epidemiology, antimicrobial resistance, and mortality of bloodstream infections in hemodialysis patients: an 11-year retrospective cohort study from southern Saudi Arabia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月17日

查看全文
  • Mona M. Alshahrani,
  • Ruqayyah Mohammed Ali Bilali,
  • Safia Abdullah Mohammed,
  • Ibrahim Tawhari,
  • Mohammed Alshehri,
  • Abdullah Jaber Asiri,
  • Hana Alahmari,
  • Basma Al Ghamdi,
  • Esmahan Tahtouh,
  • Nawal Alwadai,
  • Nermeen Mohamed Abd Elnaby,
  • Ali Somily,
  • Khalifa Binkhamis,
  • Hassan Misfer N. Taresh,
  • Sultan Saeed M. Alqahtani,
  • Ahmad Ali A. Al Farhan,
  • Hassan Yahya M. Asiri,
  • Ahmed Abdullah A. Alamoud,
  • Yazeed Mohammed S. Alqahtani,
  • Waleed Khaled A. Alzailaie,
  • Yahya Saeed Y. Alshafea,
  • Abdulah J. Alqahtani,
  • Yahya Shabi

摘要

Background

Bloodstream infections (BSI) cause major morbidity and mortality in hemodialysis patients, yet contemporary Saudi data on pathogens, antimicrobial resistance, and outcomes remain limited. We described epidemiology, antimicrobial susceptibility, multidrug-resistant (MDR) phenotype prevalence, and unadjusted associations between MDR phenotypes and 30-day in-hospital mortality among maintenance hemodialysis BSI episodes.

Methods

This single-center retrospective cohort included maintenance hemodialysis patients with positive blood cultures at Aseer Central Hospital, southern Saudi Arabia, from January 2013 through July 2024. Analyses were structured by unit of analysis: unique patients, BSI episodes (after 14-day deduplication), isolates, and hospitalized episodes for mortality. Susceptibility used CLSI M100 categorical results. Unadjusted risk ratios with 95% confidence intervals and Fisher exact tests were descriptive; no multivariable model was fitted (sparse events).

Results

201 patients contributed 297 BSI episodes and 389 isolates; 234 hospitalized. Gram-positive organisms predominated (69.0%), led by staphylococci other than Staphylococcus aureus (SOSA, 42.8%), Enterobacterales (21.2%), and S. aureus (17.2%). The 30-day in-hospital mortality was 11.1% (26/234). Linezolid (99.2%) and vancomycin (96.0%) were most active; fluoroquinolone susceptibility was low (45–49%). MDR phenotypes occurred in 24.2% of isolates (MRSA 56.4%, ESC-R 65.0%, CRE 27.3%, VRE 29.2%, CRAB 80.0%). Organism-restricted analysis found CRE-positive episodes with higher mortality than carbapenem-susceptible Enterobacterales (3/8 vs. 1/21), without conventional significance (risk ratio 7.88, 95% CI 0.95–65.06; P = 0.053).

Conclusions

BSI were predominantly gram-positive with a substantial gram-negative and MDR burden. The CRE-mortality association was unadjusted, imprecise, and hypothesis-generating, requiring confirmation in larger adjusted cohorts. Findings support local antimicrobial stewardship and active MDR surveillance.